Core Concepts
HPV vaccination before age 20 reduces the risk of cervical lesion progression.
Stats
Nearly half of the women had received at least one dose of an HPV vaccine at least 1 year before the diagnosis of cervical dysplasia.
Women vaccinated before age 15 had a 35% lower risk for progression than unvaccinated women, after adjusting for cytology, income, and education (adjusted relative risk, 0.65; 95% CI, 0.57-0.75).
Cervical cancer developed in 0.37% of the unvaccinated women and 0.13% of the vaccinated women.
Quotes
"These findings suggest that HPV vaccination status may be used to identify women at higher risk for progression, thereby enabling risk stratification at the time of CIN2 diagnosis."